Disruption to Medical Supply Chains: What Happened and How America is Adapting

Medical supply chains have faced disruptions during natural disasters and epidemics like Ebola, SARS, and norovirus; but the world had not seen a global disruption like the one caused by COVID-19. Resilient medical supply chains are essential during a global pandemic — to ensure hospitals and consumers can still get their medication, that front line workers have proper personal protection equipment (PPE), and that we have access to all the components and materials necessary for testing and vaccinations. Experts in the field Thani Jambulingam, Ph.D., professor of Pharmaceutical & Healthcare Marketing at Saint Joseph’s University, and Denise Papiernik P’19, Director of GMS Business Continuity Management at Bristol-Myers Squibb, are closely studying the effects of COVID-19 on the global supply chain and the lessons we’re learning. 

View the webinar, hosted by Rich Gallo, ‘16, to learn from these experts as they breakdown the issues the industry has faced throughout the pandemic and their insight on how the medical supply chains will change going forward into a post-coronavirus world.